Two more studies support (thrombectomy) mechanical clot retrieval for stroke.
MR CLEAN is a Dutch trial that investigated treatment of a severe form of ischaemic stroke (blockage type stroke) with thrombolysis alone (dissolving a clot with clot-busting drugs), versus treatment with both thrombolysis.
This fellowship aims to develop, tailor and target the delivery of a 6-week group intervention that offers educational, psychological and social support for people following TIA and minor stroke.
This study will investigate whether reducing blood pressure can stop bleeding in the brain after thrombolysis (a clot-busting treatment for stroke) and improve patient's outcomes.
Two new research studies were published today, supporting the use of thrombectomy (mechanical retrieval of clots in the brain) for the treatment of large ischaemic strokes.
This research is focused on assessing the relationship between the variability of the blood flow through the blood vessels supplying the brain, and the risk of stroke in patients who have already had a stroke or “mini-stroke” (TIA) in the past.
This study will investigate whether early initiation of direct anticoagulant drugs will be as safe as later initiation in stroke patients with an abnormal heart rhythm (atrial fibrillation). It will also investigate whether early initiation could lead to fewer recurrent strokes.
Can an anti-inflammatory drug (IL-1Ra) given into the skin reduce damaging inflammation in the brain and body after stroke compared to a dummy-drug?
This research project aims to better understand how particular features of the CT scan can be used to make better treatment decisions for patients with ischaemic stroke, and whether we can accurately estimate the time since the stroke began.
Published in the medical journal Stroke, a new US study suggests that treatment of chronic stroke patients with injections of modified, adult stem cells into their brains is safe, and could lead to recovery of movement that was originally lost due to stroke.